Sinopharm Group Co. Ltd. 1099.HK Stock
Sinopharm Group Co. Ltd. Price Chart
Sinopharm Group Co. Ltd. 1099.HK Financial and Trading Overview
| Sinopharm Group Co. Ltd. stock price | 19.52 HKD |
| Previous Close | 26.4 HKD |
| Open | 26.4 HKD |
| Bid | 25.9 HKD x 0 |
| Ask | 25.95 HKD x 0 |
| Day's Range | 25.4 - 26.6 HKD |
| 52 Week Range | 14.6 - 28.45 HKD |
| Volume | 4.27M HKD |
| Avg. Volume | 7.49M HKD |
| Market Cap | 80.98B HKD |
| Beta (5Y Monthly) | 0.819157 |
| PE Ratio (TTM) | 8.766892 |
| EPS (TTM) | 3.14 HKD |
| Forward Dividend & Yield | 0.87 (3.27%) |
| Ex-Dividend Date | June 19, 2023 |
| 1y Target Est | 28.64 HKD |
1099.HK Valuation Measures
| Enterprise Value | 67.62B HKD |
| Trailing P/E | 8.766892 |
| Forward P/E | 7.1685085 |
| PEG Ratio (5 yr expected) | 0.56 |
| Price/Sales (ttm) | 0.14625888 |
| Price/Book (mrq) | 1.1957424 |
| Enterprise Value/Revenue | 0.122 |
| Enterprise Value/EBITDA | 2.682 |
Trading Information
Sinopharm Group Co. Ltd. Stock Price History
| Beta (5Y Monthly) | 0.819157 |
| 52-Week Change | 43.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 28.45 HKD |
| 52 Week Low | 14.6 HKD |
| 50-Day Moving Average | 26.46 HKD |
| 200-Day Moving Average | 20.67 HKD |
1099.HK Share Statistics
| Avg. Volume (3 month) | 7.49M HKD |
| Avg. Daily Volume (10-Days) | 3.8M HKD |
| Shares Outstanding | 1.34B |
| Float | 183.2M |
| Short Ratio | N/A |
| % Held by Insiders | 0.012% |
| % Held by Institutions | 53.28% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.82 |
| Trailing Annual Dividend Yield | 3.10% |
| 5 Year Average Dividend Yield | 341.00% |
| Payout Ratio | 0.2728 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 1.55% |
| Operating Margin (ttm) | 4.14% |
| Gross Margin | 8.60% |
| EBITDA Margin | 4.55% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 553.68B HKD |
| Revenue Per Share (ttm) | 177.45 HKD |
| Quarterly Revenue Growth (yoy) | -85.39% |
| Gross Profit (ttm) | 47.43B HKD |
| EBITDA | 25.21B HKD |
| Net Income Avi to Common (ttm) | 8.64B HKD |
| Diluted EPS (ttm) | 2.96 |
| Quarterly Earnings Growth (yoy) | -74.59% |
Balance Sheet
| Total Cash (mrq) | 55.22B HKD |
| Total Cash Per Share (mrq) | 129.59 HKD |
| Total Debt (mrq) | 69.59B HKD |
| Total Debt/Equity (mrq) | 63.22 HKD |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 21.702 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Sinopharm Group Co. Ltd.
| Country | Hong Kong |
| State | N/A |
| City | Shanghai |
| Address | Sinopharm Group Building |
| ZIP | 200023 |
| Phone | 86 21 2305 2666 |
| Website | https://www.sinopharmgroup.com.cn |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | 114766 |
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Q&A For Sinopharm Group Co. Ltd. Stock
What is a current 1099.HK stock price?
Sinopharm Group Co. Ltd. 1099.HK stock price today per share is 19.52 HKD.
How to purchase Sinopharm Group Co. Ltd. stock?
You can buy 1099.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sinopharm Group Co. Ltd.?
The stock symbol or ticker of Sinopharm Group Co. Ltd. is 1099.HK.
Which industry does the Sinopharm Group Co. Ltd. company belong to?
The Sinopharm Group Co. Ltd. industry is Medical Distribution.
How many shares does Sinopharm Group Co. Ltd. have in circulation?
The max supply of Sinopharm Group Co. Ltd. shares is 3.12B.
What is Sinopharm Group Co. Ltd. Price to Earnings Ratio (PE Ratio)?
Sinopharm Group Co. Ltd. PE Ratio is 6.21656040 now.
What was Sinopharm Group Co. Ltd. earnings per share over the trailing 12 months (TTM)?
Sinopharm Group Co. Ltd. EPS is 3.14 HKD over the trailing 12 months.
Which sector does the Sinopharm Group Co. Ltd. company belong to?
The Sinopharm Group Co. Ltd. sector is Healthcare.